CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma
NCT06101381
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
81
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, Acute Lymphoblastic
Lymphoma, Non-Hodgkin
Interventions
BIOLOGICAL:
CART-19
Sponsor
University of Sao Paulo
Collaborators
[object Object]
[object Object]